PRICE T ROWE ASSOCIATES INC /MD/ - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 146 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$24,882
+94.4%
170,373
+207.5%
0.00%
+100.0%
Q2 2023$12,799
+12.4%
55,403
+17.9%
0.00%0.0%
Q1 2023$11,387
-29.0%
47,000
-14.9%
0.00%
-33.3%
Q4 2022$16,036
-99.5%
55,250
+18.5%
0.00%
Q3 2022$3,031,000
-0.1%
46,621
+10.0%
0.00%
Q2 2022$3,035,000
-31.1%
42,402
-5.6%
0.00%
Q1 2022$4,405,000
+7.3%
44,899
-7.3%
0.00%
Q4 2021$4,106,000
-11.0%
48,453
-16.2%
0.00%
Q3 2021$4,612,000
-37.9%
57,800
-24.2%
0.00%
-100.0%
Q2 2021$7,428,000
-25.8%
76,255
-10.9%
0.00%0.0%
Q1 2021$10,006,000
-47.4%
85,541
-50.0%
0.00%
-50.0%
Q4 2020$19,033,000
-8.7%
171,209
-2.5%
0.00%0.0%
Q3 2020$20,854,000
+27.9%
175,645
+22.0%
0.00%0.0%
Q2 2020$16,305,000
+422.8%
143,975
+208.2%
0.00%
Q1 2020$3,119,000
-27.8%
46,718
-1.5%
0.00%
-100.0%
Q4 2019$4,320,000
-64.8%
47,419
-66.7%
0.00%
-50.0%
Q3 2019$12,289,000
-49.2%
142,533
-38.3%
0.00%
-33.3%
Q2 2019$24,197,000
-26.1%
230,870
-11.7%
0.00%
-40.0%
Q1 2019$32,760,000
+11.3%
261,537
+0.2%
0.01%0.0%
Q4 2018$29,422,000
-72.6%
261,019
-47.9%
0.01%
-68.8%
Q3 2018$107,253,000
-32.5%
500,877
-11.8%
0.02%
-33.3%
Q2 2018$158,900,000
+631.4%
568,128
+205.4%
0.02%
+700.0%
Q1 2018$21,725,000186,0190.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$5,047,0003.31%
L1 Capital Pty Ltd 161,163$10,474,0002.05%
Avoro Capital Advisors LLC 1,535,000$99,760,0001.84%
Affinity Asset Advisors, LLC 100,000$6,499,0001.81%
GREAT POINT PARTNERS LLC 95,500$6,207,0001.50%
ARMISTICE CAPITAL, LLC 1,236,000$80,328,0001.39%
Affinity Asset Advisors, LLC 75,000$4,874,0001.36%
MPM BioImpact LLC 44,747$2,908,0000.69%
Baker Brothers Advisors 1,499,213$97,434,0000.64%
Perceptive Advisors 331,023$21,513,0000.62%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders